Gene · 3039
NIH grants1,435
NIH grants whose papers are about the gene, through NIH's grant-paper links.
321 to 340 of 1,435
Download this page as JSON| Grant | Title | HBA1 papers | Newest fiscal year |
|---|---|---|---|
| R01CA237332 | Ultrasenstive vesicle analysis in precancerous pancreatic neoplasm (IPMN) | 1 | 2024 |
| R01CA237500 | Standardized Molecular Analyses of Glioma EVs | 1 | 2024 |
| R01CA239078 | Imaging and Liquid Biopsy for Glioma Diagnosis and Treatment Monitoring | 1 | 2024 |
| R01CA245005 | POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma | 1 | 2024 |
| R01CA245533 | New Materials to Deliver mRNA: Applications in Cancer Immunotherapy | 1 | 2024 |
| R01CA246182 | Circumventing acquired carboplatin resistance in triple-negative breast cancers | 1 | 2024 |
| R01DK128907 | Characterization and functional assessment of a novel population of Wnt/beta-catenin driven adopocytes. | 1 | 2024 |
| R01EB031172 | Continuous Evolution of Proteins with Novel Therapeutic Potential | 1 | 2024 |
| R01GM118803 | Effective MS-Based Methods for Unraveling Cell Surface Protein Interactions | 1 | 2024 |
| R01HD079546 | Cellular and Molecular Basis of Human Primordial Germ Cell Specification | 1 | 2024 |
| R01HD096077 | The Role of FOS in the Ovary | 1 | 2024 |
| R01HD101540 | Genomic and Environmental Determinants of Infant Deaths in San Diego County in 2015-2022 | 1 | 2024 |
| R01HL081784 | Regulation of the interferon lamda receptor by influenza | 1 | 2024 |
| R01HL153161 | Pathways of Cell-Free Hemoglobin in Sickle Cell Nephropathy | 1 | 2024 |
| R01LM013522 | Computational approaches for the systematic detection of cell-cell interactions by spatial transcriptomics - Resubmission - 1 | 1 | 2024 |
| R25HL125451 | STIMULUS - Science & Technology Immersion for Underrepresentd Learners in the U.S. | 1 | 2024 |
| R35GM138181 | Regulation and Function of Histone H3K36 Methylation in Mammalian Chromatin | 1 | 2024 |
| R35NS097370 | Functional roles of genetic risk factors for brain disorders in neurogenesis and neurodevelopment | 1 | 2024 |
| R50CA252138 | High dimensional digital pathology to investigate the tumor micro environment and its impact on response to therapy | 1 | 2024 |
| RF1AG077474 | Myosteatosis, Cognition, and Blood Biomarkers of Alzheimer's Disease in Persons of African Ancestry | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3039/grants?page=17